UK regulator reviews AstraZeneca-Alexion deal - News - Dukascopy Bank

Tue, 25 May 2021 09:57:24 GMT
Source: Dukascopy Bank SA
 
The UK competition regulator is looking into AstraZeneca's $39B buyout of Alexion due to concerns it could hurt competition in Britain's market or elsewhere.

Back to feed
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.